​​4th Annual Cell & Gene Therapy Innovation Leaders Summit 2021

Visualising The Future

The Agenda

Three Days of Powerful Talks
01-03 Feb 2021
08:00 am

“The Global Cell and Gene Therapy Market is estimated to be worth between £10 to £40 Billion by 2025”

The Annual Cell and Gene Therapy Innovation Summit is the only executive gathering committed to creating an advanced networking platform to increase innovation and collaboration within the Cell & Gene Therapy area.

Our cutting-edge programme covers critical subjects such as progress cell gene therapy manufacturing, ATMP development, scale-up and scale-out, manufacturing data, R&D, CAR-T therapies, global regulatory affairs, stem cells, cord blood, pricing & reimbursement, improving cost efficiency, commercialization, as well how to leverage innovation to convert cutting-edge research to advance cell gene therapy manufacturing.

 

Delegates

End users who will benefit from attending include CXOs, EVPs, SVPs, VPs, Executive Directors, Directors and Global Heads responsible for:

Invited Audience

  • Tissue Engineering

  • Cell and Gene Manufacturing

  • Gene Therapy | Cell Therapy

  • Biomedical Engineering

  • Cell Line Development

  • Bioprocess Development

Quality Over Quantity

  • Technical Operations and Manufacturing

  • Investigational Material Supply Chain

  • Product Research and Development

  • Blockchain

Cohesive Networking

  • Regulatory Affairs

  • Regenerative Medicine

  • Cell Engineering

  • Immune Deficiencies

  • Stem Cell Manufacturing

  • ​Novel Vector Systems

 
 

Key Speakers

Proud to bring inspirational speakers from across the globe

Partners

 

Venue